Beijing Anzhen Hospital
Beijing, China
Location status: Recruiting
Recruiting
NCT Number: NCT07012668
Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases
The objective of this observational cohort study is to evaluate the clinical outcomes of various treatment strategies for cerebrovascular and cardiovascular diseases. Furthermore, it aims to investigate the factors that influence adverse outcomes from these treatments.
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Age ≥18 years;
- Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases.
Exclusion criteria
- The expected survival is less than 1 years;
- Simultaneously merge other serious diseases;
Treatment and study plan
Interventional or surgical treatment
ProcedureSimultaneous interventional or surgical treatment/staged interventional or surgical treatment
Primary outcomes
-
Modified Rankin Scale Score
Time frame: 90±7 days
Modified Rankin Scale（0-6）, A lower MRS score indicates better functional status for the patient.
Secondary outcomes
-
Modified Rankin Scale Score
Time frame: 7±1 days or the day discharged
Modified Rankin Scale（0-6）, A lower MRS score indicates better functional status for the patient.
-
Modified Rankin Scale Score
Time frame: 365±30 days
Modified Rankin Scale（0-6）, A lower MRS score indicates better functional status for the patient.
-
Perioperative complication rate
Time frame: 30±7 days
-
Rate of cardiovascular and cerebrovascular events
Time frame: 90±7 days
-
Rate of cardiovascular and cerebrovascular events
Time frame: 365±30 days
-
Short-term complications
Time frame: 90±7 days
-
Long-term complications
Time frame: 365±30 days
Study contacts
Contact information is provided by the study sponsor or research team.
Xiaochuan Huo, M.D.
CONTACT
Xin Tong, M.D.
CONTACT
Sponsors and collaborators
Lead sponsor
Beijing Anzhen Hospital
Other
Registry information
Important dates
- Study start
- 2024
- Primary completion
- 2027
- Study completion
- 2027
- First posted
- Jun 10, 2025
- Registry last updated
- Jun 12, 2025
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Recruiting
Oxygenation in Vascular Lesions of the Colon
NCT06230731
Vascular Lesion
Chicago, Illinois, United States
View Trial Details
Recruiting
Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder
NCT06655129
Acne Vulgaris, Acneiform Eruptions
Auxerre, France
View Trial Details
Completed
Safety and Efficacy Evaluation of SMART Camera Treatment Presets for Cutaneous Lesions Using IPL
NCT05755139
Pigmented Lesions, Vascular Lesion
Austin, Texas, United States
View Trial Details
Completed
Clinical Evaluation to Assess the Safety and Efficacy of GentleMax Pro Plus
NCT04993066
Acne, Acne Vulgaris
Marlborough, Massachusetts, United States
View Trial Details